A client taking albendazole shows decreased urine output. What action should the nurse prioritize?

In the context of a client taking albendazole who exhibits decreased urine output, prioritizing a referral to a care provider is a crucial step. Albendazole, an anthelmintic agent, can have side effects, including potential renal toxicity. When a patient experiences a significant decrease in urine output, it is essential to assess the underlying cause, as this could indicate serious renal impairment or other complications that may require specialist intervention.

Referring the client to a care provider can ensure a comprehensive evaluation of the situation. A physician may perform further diagnostics and determine whether the decrease in urine output is related to kidney function, hydration status, or a reaction to the medication. This collaborative approach enables timely intervention and potential adjustments in treatment or supportive care.

While monitoring vital signs, administering intravenous fluids, and encouraging hydration maintain importance in patient care, these actions do not address the potential complexities signified by decreased urine output as effectively as obtaining a more specialized assessment. Therefore, referral to a care provider ensures that the patient receives appropriate management based on a professional's evaluation.